These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

576 related items for PubMed ID: 28433332

  • 1. Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from a Swedish nationwide study.
    Sigvant B, Hasvold P, Kragsterman B, Falkenberg M, Johansson S, Thuresson M, Nordanstig J.
    J Vasc Surg; 2017 Aug; 66(2):507-514.e1. PubMed ID: 28433332
    [Abstract] [Full Text] [Related]

  • 2. Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study.
    Subherwal S, Patel MR, Kober L, Peterson ED, Bhatt DL, Gislason GH, Olsen AM, Jones WS, Torp-Pedersen C, Fosbol EL.
    Eur J Prev Cardiol; 2015 Mar; 22(3):317-25. PubMed ID: 24398369
    [Abstract] [Full Text] [Related]

  • 3. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.
    Sigvant B, Kragsterman B, Falkenberg M, Hasvold P, Johansson S, Thuresson M, Nordanstig J.
    J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402
    [Abstract] [Full Text] [Related]

  • 4. Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction.
    Subherwal S, Bhatt DL, Li S, Wang TY, Thomas L, Alexander KP, Patel MR, Ohman EM, Gibler WB, Peterson ED, Roe MT.
    Circ Cardiovasc Qual Outcomes; 2012 Jul 01; 5(4):541-9. PubMed ID: 22715460
    [Abstract] [Full Text] [Related]

  • 5. Myocardial infarction and peripheral arterial disease: Treatment patterns and long-term outcome in men and women results from a Swedish nationwide study.
    Sigvant B, Hasvold P, Thuresson M, Jernberg T, Janzon M, Nordanstig J.
    Eur J Prev Cardiol; 2021 Oct 25; 28(13):1426-1434. PubMed ID: 34695221
    [Abstract] [Full Text] [Related]

  • 6. Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report from the EURObservational research programme pilot survey on atrial fibrillation.
    Proietti M, Raparelli V, Laroche C, Dan GA, Janion M, Popescu R, Sinagra G, Vijgen J, Boriani G, Maggioni AP, Tavazzi L, Lip GYH, EORP-AF Gen Pilot Investigators.
    Europace; 2017 Sep 01; 19(9):1439-1448. PubMed ID: 27940934
    [Abstract] [Full Text] [Related]

  • 7. Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial.
    Patel MR, Becker RC, Wojdyla DM, Emanuelsson H, Hiatt WR, Horrow J, Husted S, Mahaffey KW, Steg PG, Storey RF, Wallentin L, James SK.
    Eur J Prev Cardiol; 2015 Jun 01; 22(6):734-42. PubMed ID: 24830710
    [Abstract] [Full Text] [Related]

  • 8. Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT.
    Inglis SC, Bebchuk J, Al-Suhaim SA, Case J, Pfeffer MA, Solomon SD, Hou YR, Pitt B, Dargie HJ, Ford I, Kjekshus J, Zannad F, Dickstein K, McMurray JJ.
    Int J Cardiol; 2013 Sep 30; 168(2):1094-101. PubMed ID: 23194780
    [Abstract] [Full Text] [Related]

  • 9. Ten Year Mortality in Different Peripheral Arterial Disease Stages: A Population Based Observational Study on Outcome.
    Sartipy F, Sigvant B, Lundin F, Wahlberg E.
    Eur J Vasc Endovasc Surg; 2018 Apr 30; 55(4):529-536. PubMed ID: 29478910
    [Abstract] [Full Text] [Related]

  • 10. Geographic variation and risk factors for systemic and limb ischemic events in patients with symptomatic peripheral artery disease: Insights from the REACH Registry.
    Abtan J, Bhatt DL, Elbez Y, Sorbets E, Eagle K, Reid CM, Baumgartner I, Wu D, Hanson ME, Hannachi H, Singhal PK, Steg PG, Ducrocq G, REACH Registry Investigators.
    Clin Cardiol; 2017 Sep 30; 40(9):710-718. PubMed ID: 28520087
    [Abstract] [Full Text] [Related]

  • 11. A prospective study about impact of renal dysfunction and morbidity and mortality on cardiovascular events after ischemic stroke.
    Penko M, Hojs Fabjan T, Bevc S, Kanič V, Hojs R.
    Cardiol J; 2014 Sep 30; 21(2):163-9. PubMed ID: 23799556
    [Abstract] [Full Text] [Related]

  • 12. Asymptomatic polyvascular disease and the risks of cardiovascular events and all-cause death.
    Zhang Q, Wang A, Zhang S, Li N, Chen S, Zhang Y, Zhou Y, Wu S, Zhao X.
    Atherosclerosis; 2017 Jul 30; 262():1-7. PubMed ID: 28463782
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of vorapaxar as approved for clinical use in the United States.
    Magnani G, Bonaca MP, Braunwald E, Dalby AJ, Fox KA, Murphy SA, Nicolau JC, Oude Ophuis T, Scirica BM, Spinar J, Theroux P, Morrow DA.
    J Am Heart Assoc; 2015 Mar 19; 4(3):e001505. PubMed ID: 25792124
    [Abstract] [Full Text] [Related]

  • 14. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH, Arpegård J, Ostergren J, Svensson P.
    Am J Hypertens; 2014 Mar 19; 27(3):363-71. PubMed ID: 24470529
    [Abstract] [Full Text] [Related]

  • 15. Cardiovascular outcomes for patients with symptomatic peripheral artery disease: A cohort study in The Health Improvement Network (THIN) in the UK.
    Cea Soriano L, Fowkes FGR, Johansson S, Allum AM, García Rodriguez LA.
    Eur J Prev Cardiol; 2017 Dec 19; 24(18):1927-1937. PubMed ID: 29053020
    [Abstract] [Full Text] [Related]

  • 16. Incidence, timing, and type of first and recurrent ischemic events in patients with and without peripheral artery disease after an acute coronary syndrome.
    Inohara T, Pieper K, Wojdyla DM, Patel MR, Jones WS, Tricoci P, Mahaffey KW, James SK, Alexander JH, Lopes RD, Wallentin L, Ohman EM, Roe MT, Vemulapalli S.
    Am Heart J; 2018 Jul 19; 201():25-32. PubMed ID: 29910052
    [Abstract] [Full Text] [Related]

  • 17. Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population.
    Nehler MR, Duval S, Diao L, Annex BH, Hiatt WR, Rogers K, Zakharyan A, Hirsch AT.
    J Vasc Surg; 2014 Sep 19; 60(3):686-95.e2. PubMed ID: 24820900
    [Abstract] [Full Text] [Related]

  • 18. Long-term cardiovascular outcome, use of resources, and healthcare costs in patients with peripheral artery disease: results from a nationwide Swedish study.
    Hasvold P, Nordanstig J, Kragsterman B, Kristensen T, Falkenberg M, Johansson S, Thuresson M, Sigvant B.
    Eur Heart J Qual Care Clin Outcomes; 2018 Jan 01; 4(1):10-17. PubMed ID: 28950310
    [Abstract] [Full Text] [Related]

  • 19. Male Sex Associated with Increased Long-term Cardiovascular Mortality after Peripheral Vascular Surgery for Atherosclerosis Despite Optimal Medical Treatment.
    Budtz-Lilly JW, Petersen CN, Pedersen TF, Eldrup N.
    Eur J Vasc Endovasc Surg; 2015 Dec 01; 50(6):767-73. PubMed ID: 26371415
    [Abstract] [Full Text] [Related]

  • 20. Aspirin Resistance Predicts Adverse Cardiovascular Events in Patients with Symptomatic Peripheral Artery Disease.
    Pasala T, Hoo JS, Lockhart MK, Waheed R, Sengodan P, Alexander J, Gandhi S.
    Tex Heart Inst J; 2016 Dec 01; 43(6):482-487. PubMed ID: 28100965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.